Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Operating Margin (2022 - 2025)

Historic Operating Margin for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to 205.18%.

  • Centessa Pharmaceuticals' Operating Margin changed N/A to 205.18% in Q1 2025 from the same period last year, while for Sep 2025 it was 1425.33%, marking a year-over-year decrease of 77153300.0%. This contributed to the annual value of 2499.39% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Centessa Pharmaceuticals' Operating Margin is 205.18%.
  • Centessa Pharmaceuticals' 5-year Operating Margin high stood at 4138.78% for Q2 2022, and its period low was 205.18% during Q1 2025.
  • In the last 3 years, Centessa Pharmaceuticals' Operating Margin had a median value of 1919.14% in 2023 and averaged 2097.27%.
  • The largest annual percentage gain for Centessa Pharmaceuticals' Operating Margin in the last 5 years was -5196800bps (2023), contrasted with its biggest fall of -22196400bps (2023).
  • Centessa Pharmaceuticals' Operating Margin (Quarter) stood at 1888.47% in 2022, then decreased by -28bps to 1368.79% in 2023, then plummeted by -115bps to 205.18% in 2025.
  • Its Operating Margin stands at 205.18% for Q1 2025, versus 1368.79% for Q4 2023 and 1582.41% for Q3 2023.